tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market
ZVRA
Zevra Therapeutics
RESEARCH TOOLSreports

Zevra Therapeutics (ZVRA) Ratios

1,049 Followers

Zevra Therapeutics Ratios

ZVRA's free cash flow for Q4 2025 was $0.96. For the 2025 fiscal year, ZVRA's free cash flow was decreased by $ and operating cash flow was $0.43. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.68 5.68 2.53 1.18 7.72
Quick Ratio
 5.63 5.63 2.47 0.85 7.72
Cash Ratio
 1.59 1.59 0.99 0.58 5.45
Solvency Ratio
 0.67 0.67 -0.72 -0.41 -0.64
Operating Cash Flow Ratio
 -0.04 -0.04 -2.05 -0.45 -1.56
Short-Term Operating Cash Flow Coverage
 -3.81 0.00 0.00 -0.89 -4.02
Net Current Asset Value
$ 92.93M$ 92.93M$ -52.43M$ -23.52M$ 52.61M
Leverage Ratios
Debt-to-Assets Ratio
 0.22 0.22 0.34 0.25 0.16
Debt-to-Equity Ratio
 0.41 0.41 1.52 0.71 0.25
Debt-to-Capital Ratio
 0.29 0.29 0.60 0.41 0.20
Long-Term Debt-to-Capital Ratio
 0.29 0.29 0.60 0.08 0.15
Financial Leverage Ratio
 1.84 1.84 4.49 2.79 1.54
Debt Service Coverage Ratio
 11.35 11.94 -12.48 -1.11 -5.11
Interest Coverage Ratio
 -7.89 -0.53 -11.84 -33.05 -127.06
Debt to Market Cap
 0.11 0.12 0.15 0.18 0.11
Interest Debt Per Share
 1.29 1.29 1.46 1.28 0.55
Net Debt to EBITDA
 <0.01 <0.01 -0.35 -0.02 1.83
Profitability Margins
Gross Profit Margin
84.22%84.52%68.59%89.28%97.82%
EBIT Margin
88.90%88.90%-350.62%-162.22%-260.51%
EBITDA Margin
92.71%92.71%-323.56%-158.56%-251.22%
Operating Profit Margin
-59.12%-3.98%-368.47%-180.63%-418.91%
Pretax Profit Margin
81.41%81.41%-381.76%-167.69%-263.80%
Net Profit Margin
78.17%78.17%-446.85%-167.69%-263.48%
Continuous Operations Profit Margin
78.17%78.17%-446.85%-167.69%-263.48%
Net Income Per EBT
96.02%96.02%117.05%100.00%99.88%
EBT Per EBIT
-137.71%-2047.67%103.61%92.83%62.97%
Return on Assets (ROA)
29.23%29.23%-59.23%-26.72%-23.21%
Return on Equity (ROE)
74.63%53.82%-266.00%-74.44%-35.64%
Return on Capital Employed (ROCE)
-25.64%-1.72%-60.39%-50.30%-41.20%
Return on Invested Capital (ROIC)
-24.58%-1.65%-60.22%-36.25%-39.20%
Return on Tangible Assets
30.42%30.42%-101.03%-46.80%-23.21%
Earnings Yield
16.01%16.79%-27.35%-19.83%-16.91%
Efficiency Ratios
Receivables Turnover
 4.58 4.58 2.25 1.58 1.22
Payables Turnover
 6.78 6.65 0.57 0.21 0.06
Inventory Turnover
 9.65 9.47 3.76 0.12 0.00
Fixed Asset Turnover
 62.59 62.59 23.31 18.00 5.70
Asset Turnover
 0.37 0.37 0.13 0.16 0.09
Working Capital Turnover Ratio
 0.56 0.90 0.72 0.58 0.11
Cash Conversion Cycle
 63.70 63.39 -384.04 1.48K -5.64K
Days of Sales Outstanding
 79.73 79.73 162.45 230.97 298.11
Days of Inventory Outstanding
 37.81 38.53 96.95 2.98K 0.00
Days of Payables Outstanding
 53.85 54.88 643.44 1.73K 5.94K
Operating Cycle
 117.54 118.27 259.40 3.22K 298.11
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.03 -0.03 -1.51 -0.95 -0.54
Free Cash Flow Per Share
 -0.04 -0.04 -1.51 -0.95 -0.55
CapEx Per Share
 0.02 0.02 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.52 1.52 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 -1.91 -1.91 0.00 -113.29 -201.26
Capital Expenditure Coverage Ratio
 -1.91 -1.91 0.00 -113.29 -201.26
Operating Cash Flow Coverage Ratio
 -0.03 -0.03 -1.16 -0.77 -1.00
Operating Cash Flow to Sales Ratio
 -0.02 -0.02 -2.95 -1.22 -1.84
Free Cash Flow Yield
-0.44%-0.49%-18.06%-14.57%-11.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.25 5.95 -3.66 -5.04 -5.91
Price-to-Sales (P/S) Ratio
 5.18 4.65 16.34 8.46 15.58
Price-to-Book (P/B) Ratio
 3.36 3.20 9.72 3.75 2.11
Price-to-Free Cash Flow (P/FCF) Ratio
 -226.83 -203.69 -5.54 -6.86 -8.42
Price-to-Operating Cash Flow Ratio
 -325.36 -310.13 -5.54 -6.92 -8.46
Price-to-Earnings Growth (PEG) Ratio
 0.04 -0.04 -0.05 -0.08 0.09
Price-to-Fair Value
 3.36 3.20 9.72 3.75 2.11
Enterprise Value Multiple
 5.60 5.03 -5.40 -5.35 -4.37
Enterprise Value
 552.69M 496.39M 412.25M 232.93M 111.62M
EV to EBITDA
 5.60 5.03 -5.40 -5.35 -4.37
EV to Sales
 5.19 4.66 17.46 8.48 10.98
EV to Free Cash Flow
 -227.16 -204.02 -5.92 -6.89 -5.93
EV to Operating Cash Flow
 -345.86 -310.63 -5.92 -6.95 -5.96
Tangible Book Value Per Share
 2.60 2.60 -0.74 -0.34 2.18
Shareholders’ Equity Per Share
 2.80 2.80 0.86 1.74 2.18
Tax and Other Ratios
Effective Tax Rate
 0.04 0.04 -0.17 0.00 <0.01
Revenue Per Share
 1.92 1.92 0.51 0.77 0.29
Net Income Per Share
 1.50 1.50 -2.28 -1.30 -0.78
Tax Burden
 0.96 0.96 1.17 1.00 1.00
Interest Burden
 0.92 0.92 1.09 1.03 1.01
Research & Development to Revenue
 0.12 0.12 1.78 1.45 1.95
SG&A to Revenue
 0.73 0.73 2.32 0.00 1.51
Stock-Based Compensation to Revenue
 0.12 0.12 0.63 0.22 0.42
Income Quality
 -0.02 -0.02 0.66 0.73 0.45
Currency in USD